Decreased FENDRR and LincRNA-p21 expression in atherosclerotic plaque

• Published in: Anatolian journal of cardiology Vol. 19; no. 2; pp. 131 - 136
• Main Authors: Çekin, Nilgün, Özcan, Arzu, Göksel, Sabahattin, Arslan, Serdal, Pınarbaşı, Ergün, Berkan, Öcal
• Format: Journal Article
• Language: English
• Published: Turkey Kare Publishing 01-02-2018
• Subjects: Atherosclerosis; Coronary vessels; Heart surgery; Original Investigation; Stents; Veins & arteries
• ISSN: 2149-2263; 2149-2271
• DOI: 10.14744/AnatolJCardiol.2017.8081

Cardiovascular diseases are the most important cause of mortality worldwide, particularly atherosclerosis. Recently, lncRNAs affecting atherosclerotic progression have been reported in vascular smooth muscle cells, endothelial cells, and monocytes, suggesting that lncRNAs play an important role in atherosclerosis.
In recent clinical studies, nowadays, it was determined that internal mammary bypass grafts are closest to ideal grafts in coronary artery bypass surgery. In this study, we used tissue samples taken from atherosclerotic coronary arteries and the internal mammary artery (IMA) during coronary artery bypass surgery. Using RT-PCR, we investigated the role of two lncRNAs, FENDRR and LincRNA-p21, by comparing their expression levels in coronary artery plaques and normal mammary arteries of 20 atherosclerotic patients.
We found that the FENDRR and LincRNA-p21 expressions decreased by approximately 2 and 7 fold in coronary artery plaques, respectively, compared with those in IMA, which is known to have no plaque development.
This study was the first to use mammary artery tissues of the same patients as a control and to study FENDRR expression. Our data may provide helpful insights regarding the association of lncRNAs and atherosclerosis.